UNSPSC 51282703: Vancomycin hydrochloride

This classification denotes an antibiotic with the molecular formula C66H75Cl2N9O24.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 71WO621TJD, chemically known as vancomycin, monohydrochloride but generally known as vancomycin hydrochloride, which bears US NIH Compound Identifier 14970. European Medicines Agency schedules Vancomycin hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05077MIG. Most nations schedule vancomycin hydrochloride under HS 29419000 and SITC 54139.

UNSPSC 51282703 Vancomycin hydrochloride is a Commodity code covering a specific injectable antibiotic pharmaceutical product. State and local governments procure vancomycin hydrochloride through pharmaceutical warehouse and supplier contracts, typically as part of broader emergency preparedness, public health, or community health initiatives. The code serves health departments, county health systems, and special-purpose health districts that stock critical medications for emergency response, infection control, and routine clinical use.

The recent opportunities block shows limited activity directly tied to vancomycin hydrochloride. The Illinois Department of Public Health awarded a pharmaceutical warehouse piggyback contract through MMCAP Infuse to Chartwell Rx LLC on August 28, 2026 for Doxycycline Hyclate and Ciprofloxacin Hydrochloride totaling $2,999,999.11 over three years—a completed award under IFB, not an open solicitation and not covering vancomycin. Seminole County, Florida posted an IFB on June 30, 2026 (due July 26, 2023 per the source date discrepancy) for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually, also outside the vancomycin scope. The source provides no open solicitations or recent contract awards for vancomycin hydrochloride itself under this code. Procurement activity under this code appears limited in recent state and local notice data.